References
- ViganòP1ParazziniFSomiglianaEVercelliniPEndometriosis: epidemiology and aetiological factorsBest Pract Res Clin Obstet Gynaecol20041817720015157637
- StreuliIde ZieglerDSantulliPAn update on the pharmacological management of endometriosisExpert Opin Pharmacother20131429130523356536
- LarosaMFacchiniFPozzoliGLeoneMGrandeMMonicaBEndometriosis: aetiopathogenetic basisUrologia201077Suppl 17111
- FalconerHPregnancy outcomes in women with endometriosisSemin Reprod Med20133117818223446866
- MacerMLTaylorHSEndometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertilityObstet Gynecol Clin North Am20123953554923182559
- SinaiiNPlumbKCottonLDifferences in characteristics among 1,000 women with endometriosis based on extent of diseaseFertil Steril20088953854517498711
- European Society of Human Reproduction and Embryology. Endometriosis Guideline Development GroupManagement of women with endometriosis: Guideline of the European Society of Human Reproduction and Embryology Available from: http://endometriosis.eshre.eu/docs/ESH-REguidelineonendometriosis2013_3.pdfAccessed July 16, 2014
- NobleLSSimpsonERJohnsABulunSEAromatase expression in endometriosisJ Clin Endocrinol Metab19968111741798550748
- Al-JefoutMTokushigeNHey-CunninghamAJManconiFNgCSchulkeLMicroanatomy and function of the eutopic endometrium in women with endometriosisExpert Rev Obstet Gynecol2009416179
- FraserISTokushigeNHey-CunninghamBerbicMNgCHMPelvic mechanisms involved in the pathophysiology of pain in endometriosisGiudiceLEversJLHHealyDLEndometriosis: Science and PracticeBlackwell PublishingLondon, UK2012 Chap 21212229
- BerbicMHey-CunninghamAJNgCThe role of the immune response in endometriosisMitchellLAEndometriosis: symptoms, diagnosis and treatmentsNova Science Publishers Inc Chap 22009132
- HarelZDysmenorrhea in adolescents and young adults: etiology and managementJ Pediatr Adolesc Gynecol20061936337117174824
- HaradaTDysmenorrhea and endometriosis in young womenYonago Acta Med201356818424574576
- KleinSD’HoogheTMeulemanCDirksenCDunselmanGSimoensSWhat is the societal burden of endometriosis-associated symptoms? A prospective Belgian studyReprod BioMed Online20142811612424268732
- SimoensSDunselmanGDirksenCThe burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centresHum Reprod2012271292129922422778
- SepulcriaRPAmaralVFDepressive symptoms, anxiety, and quality of life in women with pelvic endometriosisEur J Obstet Gynecol Reprod Biol2009142535619010584
- GaoXYehYCOutleyJSimonJBottemanMSpaldingJHealth-related quality of life burden of women with endometriosis: a literature reviewCurr Med Res Opin2006221787179716968582
- VercelliniPBarbaraGSomiglianaEBianchiSAbbiatiAFedeleLComparison of contraceptive ring and patch for the treatment of symptomatic endometriosisFertil Steril2010932150216119328469
- YlanenKLaatikainenTLähteenmäkiPMoo-YoungAJSubdermal progestin implant (Nesterone) in the treatment of endometriosis: clinical response to various dosesActa Obstet Gynecol Scand20038216717212648180
- MansourDThe benefits and risks of using a levonorgestrel-releasing intrauterine system for contraceptionContraception20128522423422067761
- WeisbergEDevelopments in contraceptionExpert Opin Pharmacother20141520321024283671
- KaislasuoJSuhonenSGisslerMLähteenmäkiPHeikinheimoOIntrauterine contraception: incidence and factors associated with uterine perforation – a population-based studyHum Reprod2012272658266322763376
- VercelliniPAimiGPanazzaSDe GiorgiOPesoleACrosignaniPGA levonorgestrel-releasing intrauterine system for the treatment of dysmenorrhea associated with endometriosis: a pilot studyFertil Steril19997250550810519624
- LockhatFBEmemboluJOKonjeJCThe evaluation of the effectiveness of an intrauterine-administered progestogen (levonorgestrel) in the symptomatic treatment of endometriosis and in the staging of the diseaseHum Reprod20041917918414688179
- LockhatFBEmemboluJOKonjeJCThe efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-upHum Reprod20052078979315608040
- OrtizMECroxattoHBCopper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of actionContraception200775S16S3017531610
- LähteenmäkiPBardinCWElomaKSelection and performance of the levonorgestrel-releasing intrauterine systemActa Obstet Gynecol Scand19971646974
- HidalgoM1BahamondesLPerrottiMDiazJDantas-MonteiroCPettaCBleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two yearsContraception20026512913211927115
- MaruoTLaoag-FernandezJBPakarinenPMurakoshiHSpitzIMJohanssonEEffects of the levonorgestrel-releasing intrauterine system on proliferation and apoptosis in the endometriumHum Reprod2001162103210811574499
- LuukkainenTPakarinenPToivonenJProgestin-releasing intrauterine systemsSemin Reprod Med20011935536311727177
- BahamondesLPettaCAFernandesAMonteiroIUse of the levonorgestrel-releasing intrauterine system in women with endometriosis, chronic pelvic pain and dysmenorrheaContraception200775Suppl 6S134S13917531605
- CroxattoHBMäkäräinenLThe pharmacodynamics and efficacy of Implanon. An overview of the dataContraception19985891S97S10095979
- MeirikOFraserISd’ArcanguesCWHO Consultation on Implantable Contraceptives for WomenImplantable contraceptives for womenHum Reprod Update20039495912638781
- MansourDKorverTMarintcheva-PetrovaMFraserISThe effects of Implanon on menstrual bleeding patternsEur J Contracept Reprod Health Care200813Suppl 1132818330814
- WeisbergEFraserIAustralian women’s experience with ImplanonAust Fam Physician20053469469616113711
- HidalgoMMLisondoCJuliatoCTEspejo-ArceXMonteiroIBahamondesLOvarian cysts in users of Implanon® and Jadelle® subdermal contraceptive implantsContraception20067353253616627041
- WalchKUnfriedaGHuberaJImplanon® versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis – a pilot studyContraception200979293419041438
- PonpuckdeeJTaneepanichskulSThe effects of Implanon in the symptomatic treatment of endometriosisJ Med Assoc Thai200588Suppl 2S7S10
- CrosignaniPGLucianoARayABergqvistASubcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated painHum Reprod20062124825616176939
- SimonMAShulmanLPSubcutaneous versus intramuscular depot methoxyprogesterone acetate: a comparative reviewWomens Health (Lond Engl)2006219119719803889
- SchlaffWDCarsonSALucianoARossDBergqvistASubcutaneous injection of depot medroxyprogesterone acetate compared with leupro-lide acetate in the treatment of endometriosis-associated painFertil Steril20068531432516595206
- BrownJKivesSAkhtarMProgestagens and anti-progestagens for pain associated with endometriosisCochrane Database Syst Rev20123CD002122
- KaunitzAMDarneyPDRossDWolterKDSperoffLSubcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral densityContraception20098071719501210
- HarelZJohnsonCCGoldMARecovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injectionsContraception20108128129120227543
- RennerRMAdelmanABKaunitzAMDepot medroxyprogesterone acetate contraceptive injections and skeletal healthWomens Health (Lond Engl)2010633934220426597
- LopezLMEdelmanAChenMOtternessCTrussellJHelmerhorstFMProgestin-only contraceptives: effects on weightCochrane Database Syst Rev20137CD008815
- RiceCFKillickSRDiebenTCoelingh BenninkHA comparison of the inhibition of ovulation achieved by desogestrel 75 µg and levonorg-estrel 30 µg dailyHum Reprod19991498299510221231
- KorverTKlippingCHeger-MahnDDuijkersIvan OstaGDiebenTMaintenance of ovulation inhibition with the 75-µg desogestrel-only contraceptive pill (Cerazette®) after scheduled 12-h delays in tablet intakeContraception20057181315639065
- AhrendtHJKarcktUPichlTMuellerTErnstUThe effects of an oestrogen-free, desogestrel-containing oral contraceptive in women with cyclical symptoms: results from two studies on oestrogen-related symptoms and dysmenorrhoeaEur J Contracept Reprod Health Care20071235436117853159
- VercelliniPFrontinoGDe GiorgiOPietropaoloGPasinRCrosignaniPGContinuous use of an oral contraceptive for endometriosis- associated recurrent dysmenorrhea that does not respond to a cyclic pill regimenFertil Steril20038056056312969698
- FerrariSPersicoPDi PuppoFContinuous low-dose oral contraceptive in the treatment of colorectal endometriosis evaluated by rectal endoscopic ultrasonographyActa Obstet Gynecol Scand20129169970322268632
- HaradaTMomoedaMTaketaniYHoshiaiHTerakawaNLow-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trialFertil Steril2008901583158818164001
- MabroukMSolfriniSFrascàCA new oral contraceptive regimen for endometriosis management: preliminary experience with 24/4-day drospirenone/ethinylestradiol 3 mg/20 mcgGynecol Endocrinol20122845145422132832
- MeresmanGFAugéLBarañaoRILombardiETesoneMSueldoCOral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosisFertil Steril2002771141114712057719
- DavisLKennedySSMooreJPrenticeAModern combined oral contraceptives for pain associated with endometriosisCochrane Database Syst Rev20073CD001019
- GuzickDSHuangLSBroadmanBANealonMHornsteinMDRandomized trial of leuprolide versus continuous oral contraceptives in the treatment of endometriosis-associated pelvic painFertil Steril2011951568157321300339
- ChapronCSouzaCBorgheseBOral contraceptives and endometriosis: the past use of oral contraceptives for treating severe primary dysmenorrhea is associated with endometriosis, especially deep infiltrating endometriosisHum Reprod2011262028203521642638
- VercelliniPSomiglianaEViganòPDe MatteisSBarbaraGFedeleLPost-operative endometriosis recurrence: a plea for prevention based on pathogenetic, epidemiological and clinical evidenceReprod Biomed Online20102125926520541975
- VlahosNVlachosATriantafyllidouOVitoratosNCreatsasGContinuous versus cyclic use of oral contraceptives after surgery for symptomatic endometriosis: a prospective cohort studyFertil Steril20131001337134223953327
- SeracchioliRMabroukMFrascàCLong-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trialFertil Steril201093525618973896
- VercelliniPSomiglianaEDaguatiRViganoPMeroniFCrosignaniPGPostoperative oral contraceptive exposure and risk of endometrioma recurrenceAm J Obstet Gynecol2008198504.e1e518241819
- VercelliniPDe MatteisSSomiglianaEBuggioLFrattaruoloMPFedeleLLong-term adjuvant therapy for the prevention of postoperative endometrioma recurrence: a systematic review and meta-analysisActa Obstet Gynecol Scand20139281622646295
- TanmahasamutPRattanachaiyanontMAngsuwathanaSTechatraisakKIndhavivadhanaSLeerasiriPPostoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trialObstet Gynecol201211951952622314873
- Abou-SettaAMHoustonBAl-InanyHGFarquharCLevonorgestrel- releasing intrauterine device (LNG-IUD) for symptomatic endo-metriosis following surgeryCochrane Database Syst Rev20131CD005072
- ZhouJLeiZWLüJQConservative surgery combined with depot medroxyprogesterone acetate in treatment of moderate or severe endometriosisZhonghua Fu Chan Ke Za Zhi20054058 Chinese15774083
- GoldsteinDPdeCholnokyCLeventhalJMEmansSJNew insights into the old problem of chronic pelvic painJ Pediatr Surg197914675680162146
- American College of Obstetricians and Gynecologists Adolescent Health Care Committee OpinionAdolescents and long-acting reversible contraception: implants and intrauterine devices10162012 Available from: http://www.acog.org/About-ACOG/ACOG-Departments/Adolescent-Health-Care/Adolescents-and-Long-Acting-Reversible-Contraception/Accessed April 12, 2015
- RisserWLGefteraLRBarrattMSRisserJMHWeight change in adolescents who used hormonal contraceptionJ Adolesc Health19992443343610401972
- ManganSALarsenPGHudsonSOverweight teens at increased risk for weight gain while using depot medroxyprogesterone acetateJ Pediatr Adolesc Gynecol200215798212057528
- WilliamsRLHenselDJFortenberryJDSelf-administration of subcutaneous depot medroxyprogesterone acetate by adolescent womenContraception20138840140723294549
- BahamondesMVHidalgoMMBahamondesLMonteiroIEase of insertion and clinical performance of the levonorgestrel-releasing intrauterine system in nulligravidasContraception201184e11e1622018132
- PillaiMO’BrienKHillEThe levonorgestrel intrauterine system (Mirena) for the treatment of menstrual problems in adolescents with medical disorders, or physical or learning disabilitiesBJOG201011721622119874296
- SuhonenaSHaukkamaaMJakobssonTRauramoIClinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative studyContraception20046940741215105064
- YoostJLaJoieASHertweckPLovelessMUse of the levonorgestrel intrauterine system in adolescents with endometriosisJ Pediatr Adolesc Gynecol20132612012423518190
- Al-JefoutMPalmerJFraserISSimultaneous use of a levonorgestrel intrauterine system and an etonogestrel subdermal implant for debilitating adolescent endometriosisAust N Z J Obstet Gynaecol20074724724917550495
- DinermanLMWilsonMDDugganAKJoffeAOutcomes of adolescents using levonorgestrel implants vs oral contraceptives or other contraceptive methodsJAMA Pediatrics1995149967972
- LewisaLNDohertyDAHickeyMSkinnerSRImplanon as a contraceptive choice for teenage mothers: a comparison of contraceptive choices, acceptability and repeat pregnancyContraception20108142142620399949